ARCHIVES

“Whatever Happened To…?” ACS Follows Up Five Years Later

This article is from The Cancer Letter archive.

Vol. 03 No. 34 | August 26, 1977

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

In Brief: Mueller, Rosenberg Head AACR; Elion, Schein Presidents Elect; PHS Offers epidemiology Training

May 7, 1982

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990